A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression

Abstract
No abstract available
Funding Information
  • National Institute of Mental Health (1 R21 MH067055-01A1)
  • GlaxoSmithKline
  • Stanley Medical Research Institute (02T-158)